Cargando…

Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases

OBJECTIVES: To evaluate the long-term benefits of tear-exchangeable, limbal-rigid contact lens (CL) wear therapy in patients with Stevens–Johnson syndrome (SJS)–associated ocular sequelae. METHODS: This retrospective study evaluated 50 eyes of 41 SJS patients (15 men and 26 women) who underwent limb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshikawa, Yamato, Ueta, Mayumi, Kinoshita, Shigeru, Kida, Teruyo, Sotozono, Chie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Eye & Contact Lens: Science & Clinical Practice 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513020/ https://www.ncbi.nlm.nih.gov/pubmed/37053071 http://dx.doi.org/10.1097/ICL.0000000000000989

Ejemplares similares

Limbal-Rigid Contact Lens Wear for the Treatment of Ocular Surface Disorders: A Review
por: Aziza, Yulia, et al.
Publicado: (2022)

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2017)

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
por: Aziza, Yulia, et al.
Publicado: (2022)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
por: Ueta, Mayumi, et al.
Publicado: (2021)

Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
por: Ueta, Mayumi, et al.
Publicado: (2014)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2019)

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
por: Ueta, Mayumi, et al.
Publicado: (2008)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
por: Kawai, Yosuke, et al.
Publicado: (2021)

Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2020)

HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
por: Ueta, Mayumi, et al.
Publicado: (2012)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
por: Kinoshita, Fumie, et al.
Publicado: (2021)

Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
por: Ueta, Mayumi, et al.
Publicado: (2019)

Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops
por: Ueta, Mayumi, et al.
Publicado: (2014)

HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications
por: Ueta, Mayumi, et al.
Publicado: (2015)

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients
por: Saito, Yoshiro, et al.
Publicado: (2014)

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Association of IKZF1 SNPs in cold medicine-related Stevens–Johnson syndrome in Thailand
por: Chantaren, Patchima, et al.
Publicado: (2019)

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
por: Nakatani, Ken, et al.
Publicado: (2019)

Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population
por: Kannabiran, Chitra, et al.
Publicado: (2017)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
por: Butt, Gibran F., et al.
Publicado: (2021)

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement
por: Ueta, Mayumi, et al.
Publicado: (2014)

Characteristics of meibomian gland dysfunction in patients with Stevens–Johnson syndrome
por: Shrestha, Tina, et al.
Publicado: (2019)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016)

Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications
por: Ueta, Mayumi, et al.
Publicado: (2014)

Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders
por: Ueta, Mayumi, et al.
Publicado: (2011)

Difference in the plasma level of miR‐628‐3p in atopic dermatitis patients with/without atopic keratoconjunctivitis
por: Ueta, Mayumi, et al.
Publicado: (2021)

"Síndrome de Stevens-Johnson"
por: Mortera Carbonell, María de los Angeles
Publicado: (1992)

Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019)

Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study
por: Ueta, Mayumi, et al.
Publicado: (2012)

Differential expression of tear film cytokines in Stevens–Johnson syndrome patients and comparative review of literature
por: Koduri, Madhuri Amulya, et al.
Publicado: (2021)

Cataract surgery in Steven Johnson syndrome
por: Srinivasan, Renuka, et al.
Publicado: (2007)

Stevens-Johnson Syndrome Induced by Vandetanib
por: Yoon, Jimi, et al.
Publicado: (2011)

Stevens Johnson Syndrome associated with Lamotrigine
por: Parveen, Shama, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c4sndk44274kkamrj5fncv7une